Open Meeting Announcement - Multiple MolDX Policies MolDX: Molecular Testing for Identification and Management of Hereditary Transthyretin Amyloidosis and MolDX: Genetic Testing for Heritable Thoracic Aortic Disease - October 10, 2024

Date Posted: August 29, 2024

This article has been published for notice under contract numbers: 01111 (CA), 01211 (AS, GU, HI, NMI), 01311 (NV), and 01911 (CA, HI & Territories).

Noridian Healthcare Solutions will be hosting an Open Public Meeting on Thursday, October 10, 2024, from 1 p.m. to 3 p.m. CT.

Advance Registration is required.

  • Registration deadline to present comments on an LCD will close on October 3, 2024, at 11:59 pm CDT.
  • General Registration deadline to participate by listen-only mode will close on October 9, 2024, at 11:59 pm CDT.

Proposed Local Coverage Determination (LCDs) and Local Coverage Article (LCAs)

  • MolDX: Molecular Testing for Identification and Management of Hereditary Transthyretin Amyloidosis DL39948
  • Billing and Coding: MolDX: Molecular Testing for Identification and Management of Hereditary Transthyretin Amyloidosis DA59872
  • MolDX: Genetic Testing for Heritable Thoracic Aortic Disease DL39944
  • Billing and Coding: MolDX: Genetic Testing in Heritable Thoracic Aortic Disease DA59868
  • View meeting details and register now from the MolDX Open Public Meeting webpage.
Last Updated Aug 29 , 2024